These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Superficial mucoceles in chronic graft-versus-host disease: a case report and review of the literature. Balasubramaniam R; Alawi F; DeRossi S Gen Dent; 2009; 57(1):82-8. PubMed ID: 19146147 [TBL] [Abstract][Full Text] [Related]
6. An overview of chronic oral graft-vs-host disease following pediatric hematopoietic stem cell transplantation. da Fonseca MA; Hong C Pediatr Dent; 2008; 30(2):98-104. PubMed ID: 18481573 [TBL] [Abstract][Full Text] [Related]
7. Chronic graft versus host disease of oral mucosa: review of available therapies. Imanguli MM; Pavletic SZ; Guadagnini JP; Brahim JS; Atkinson JC Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):175-83. PubMed ID: 16448918 [TBL] [Abstract][Full Text] [Related]
8. Detection of human herpesvirus 6 in patients with oral chronic graft-vs-host disease following allogeneic progenitor cell transplantation. Pereira CM; de Almeida OP; Corrêa ME; Costa FF; de Souza CA; Barjas-Castro ML Oral Dis; 2007 May; 13(3):329-34. PubMed ID: 17448218 [TBL] [Abstract][Full Text] [Related]
9. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus. Eckardt A; Starke O; Stadler M; Reuter C; Hertenstein B Oral Oncol; 2004 Sep; 40(8):811-4. PubMed ID: 15288836 [TBL] [Abstract][Full Text] [Related]
11. Budesonide: a novel treatment for oral chronic graft versus host disease. Elad S; Or R; Garfunkel AA; Shapira MY Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Mar; 95(3):308-11. PubMed ID: 12627101 [TBL] [Abstract][Full Text] [Related]
12. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
13. Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease. Colombo AA; Rusconi C; Esposito C; Bernasconi P; Caldera D; Lazzarino M; Alessandrino EP Transplantation; 2006 Apr; 81(8):1087-92. PubMed ID: 16641591 [TBL] [Abstract][Full Text] [Related]
14. Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens. Cutler C; Li S; Kim HT; Laglenne P; Szeto KC; Hoffmeister L; Harrison MJ; Ho V; Alyea E; Lee SJ; Soiffer R; Sonis S; Antin JH Biol Blood Marrow Transplant; 2005 May; 11(5):383-8. PubMed ID: 15846292 [TBL] [Abstract][Full Text] [Related]
15. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease. Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954 [TBL] [Abstract][Full Text] [Related]
17. How can we help patients with refractory chronic graft versus host disease- single centre experience. Rzepecki P; Barzal J; Sarosiek T; Oborska S; Szczylik C Neoplasma; 2007; 54(5):431-6. PubMed ID: 17688373 [TBL] [Abstract][Full Text] [Related]
18. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005]. Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910 [TBL] [Abstract][Full Text] [Related]